Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Global Myasthenia Gravis Treatment Market: Forecast and Trends
... type, treatment by drug and region. Report Includes: 54 data tables and 47 additional tables An overview and analysis of the global market for myasthenia gravis (MG) treatments Analyses of market trends, with historical market ... Read More
-
Global Autoimmune Disease Diagnostics Market 2024-2028
... autoimmune disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Immunoassay Market based on by Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Technology [Radioimmunoassay (RIA), Enzyme-linked Immunosorbent Assay (ELISA), Enzyme-linked Fluorescent Assay (ELFA), Chemiluminescence Immunoassay (CLIA), Rapid Test, Others], Indication (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Diseases, Autoimmune Diseases, Others), End User (Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical and Biotechnology Companies, Academic) and Regional Outlook– Global Forecast up to 2030
... Cardiology, Endocrinology, Infectious Diseases, Autoimmune Diseases, Others), End User (Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical and Biotechnology Companies, Academic) and Regional Outlook– Global Forecast up to 2030 A significant amount of secondary sources, directories, and ... Read More
-
Nanobody Market Research Report Forecast till 2030
... interest in nanobody innovative work are driving market development. Nanobodies are little counter acting agent parts that enjoy a few upper hands over conventional antibodies, like more prominent strength, better tissue infiltration, and decreased immunogenicity. ... Read More
-
HPAPI and Cytotoxic Drug Manufacturing Market (4th Edition), 2022-2035
... and cytotoxic drugs have emerged as one of the key areas of interest for researchers and drug developers worldwide. As is well known, HPAPIs are pharmacologically active compounds which are capable of eliciting a biological ... Read More
-
Biopharmaceutical Market Size, Share, and Analysis, By Product Type (Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other), By Service (Custom Testing / Customer Proprietary Testing, Laboratory Testing, Compendial, and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious Diseases, Hormonal Disorders, Neurological Diseases, Cardiovascular Diseases, and Other) and Regional Forecasts, 2022-2032
... and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious ... Read More
-
Global Autoimmune Diagnostics Market - 2023-2030
... period 2023-2030. Autoimmune diseases have no cure; addressing and managing the symptoms is very important. Autoimmune disease diagnosis helps detect the illness's root cause so that the proper treatment is given to the patient to ... Read More
-
Global Chronic Immune Thrombocytopenia Market - 2023-2030
... the forecast period 2023-2030. Chronic Immune Thrombocytopenia (ITP) is an autoimmune bleeding disorder that occurs due to decreased platelet secretion, preventing blood clotting. An average platelet count ranges from approximately 150,000 to 400,000 per blood ... Read More
-
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
... and opportunities, R&D strategies, pipeline assessment, and market outlook. Myasthenia Gravis (MG) is an autoimmune and neuromuscular disease that is characterized by muscle weakness and fatigue. In the majority of patients, the disease is initially ... Read More
-
Global Rheumatoid Arthritis Drugs Market 2024-2028
... rheumatoid arthritis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
South & Central America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The South & Central America clinical trials market is expected to grow from US$ 1,794.69 million in 2022 to US$ 2,523.98 million by 2028. It ... Read More
-
Middle East & Africa Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Middle East & Africa clinical trials market is expected to grow from US$ 1,524.94 million in 2022 to US$ 1,923.39 million by 2028. It ... Read More
-
Europe Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Europe clinical trials market is expected to grow from US$ 15,739.35 million in 2022 to US$ 21,643.87 million by 2028. It is estimated to grow at a ... Read More
-
North America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The North America clinical trials market is expected to grow from US$ 27,322.28 million in 2022 to US$ 36,818.15 million by 2028. It is estimated to grow ... Read More
-
Asia Pacific Clinical Trials Market Forecast to 2028 – Regional Analysis – by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Asia Pacific clinical trials market is expected to grow from US$ 8,670.68 million in 2022 to US$ 13,114.04 million by 2028. It is estimated to grow ... Read More
-
Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 5.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028. The increasing incidences of autoimmune diseases, rising sales of insurance policies, and the growing use of EMRs represent ... Read More
-
2023 Blood & AutoImmune Diseases Global Market Size & Growth Report with COVID-19 & Recession Risk Impact
... and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with forecasts for 2023 and 2027. The historical ... Read More
-
US Axial Spondyloarthritis Market outlook to 2028
... causing pain and inflammation in the spine. There are two types of Axial Spondyloarthritis, i.e., Ankylosing Spondylitis and Non-radiographic Spondyloarthritis. According to Ken Research, this market is anticipated to grow at a CAGR of 9.5% ... Read More
-
Hyperimmune Globulins Market Forecasts to 2030 – Global Analysis By Type (Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Rho(D) Immunoglobulins, Tetanus Immunoglobulins and Other Types), By End User (Hospitals & Clinics, Blood Banks and Donation Centers, Government Institutions and Other End Users) and By Geography
... Institutions and Other End Users) and By Geography According to Stratistics MRC, the Global Hyperimmune Globulins Market is accounted for $2.01 billion in 2023 and is expected to reach $3.69 billion by 2030 growing at ... Read More
-
Allogeneic Stem Cell Transplantation Market, By Source (Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Adipose Tissue, Dental Pulp, Others), By Application (Cancer, Autoimmune Diseases, Blood Disorders, Cardiac Disorders, Neurological Disorders, Diabetes, Others), By End User (Hospitals, Research Institutes, Specialty Clinics, Others), By Cell Type (Allogeneic MSCs, Allogeneic HSCs, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... (Hospitals, Research Institutes, Specialty Clinics, Others), By Cell Type (Allogeneic MSCs, Allogeneic HSCs, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Allogeneic stem cell transplantation is a medical ... Read More
-
Biosimilars Market by Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Indication (Autoimmune Diseases, Blood Disorders, Chronic Diseases), Manufacturing - Global Forecast 2023-2030
... 2030 from USD 33.27 billion in 2022, at a CAGR of 23.18% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category ... Read More
-
Global Bispecific Antibodies Market Size Study & Forecast, by Indication (Cancer, Inflammatory & Autoimmune Disorders, Others), and Regional Analysis, 2023-2030
... anticipated to grow with a healthy growth rate of more than 44.0% over the forecast period 2023-2030. Bispecific antibodies are a class of therapeutic proteins created to attach to two distinct target molecules simultaneously. These ... Read More
-
Cutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Cutaneous Lupus Erythematosus Clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Lupus ... Read More
-
Global Systemic Lupus Erythematosus (SLE) Market (by Product Type, Route of Administration, End User, & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)
... autoimmune disease that affects almost every organ and organ system in the human body. The immune system attacks the body's own tissues in this condition, causing significant inflammation and tissue damage in the organs implicated. ... Read More
-
Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Cardiovascular, Infectious, Autoimmune Diseases) Product, End User - Global Forecast to 2030
... by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Cardiovascular, Infectious, Autoimmune Diseases) Product, End User—Global Forecast to 2030 The global multiplex assays market is expected to ... Read More
Research Assistance
